共 215 条
[11]
Bachelot MF(2012)Prospective cohort study of spinal muscular atrophy types 2 and 3 Neurology 79 1889-97
[12]
Lathrop MG(2016)Patterns of disease progression in type 2 and 3 SMA: implications for clinical trials Neuromuscul Disord 26 126-31
[13]
Lefebvre S(2018)Ambulatory function in spinal muscular atrophy: age-related patterns of progression PLoS ONE 13 e0199657-17
[14]
Bürglen L(2020)Clinical variability in spinal muscular atrophy type III Ann Neurol 88 1109-98
[15]
Reboullet S(2020)Muscle strength and motor function in adolescents and adults with spinal muscular atrophy Neurology 95 e1988-46
[16]
Clermont O(2006)Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron Mol Cell Biol 26 1333-32
[17]
Burlet P(2011)Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy Sci Transl Med 3 72ra18-35
[18]
Viollet L(2017)Nusinersen versus Sham control in infantile-onset spinal muscular atrophy N Engl J Med 377 1723-74
[19]
Lefebvre S(2021)2021 motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analys Orphanet J Rare Dis 16 430-25
[20]
Burlet P(2018)Nusinersen versus Sham control in later-onset spinal muscular atrophy N Engl J Med 378 625-6